Comparison of Epidemiology and Clinical Outcomes of Influenza A & B Cases in Manitoba, Canada
NCT01683630 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1849
Last updated 2016-10-10
Summary
This study compares the epidemiology and clinical outcomes of laboratory confirmed influenza type A to type B following clinical diagnosis of influenza. Multivariate models are used to assess the effects of influenza type on clinical outcomes while accounting for potential confounders.
Conditions
Sponsors & Collaborators
-
International Centre for Infectious Diseases, Canada
lead OTHER
Principal Investigators
-
Salah Mahmud, MD, PhD · Associate Professor, University of Manitoba
Eligibility
- Min Age
- 6 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2012-09-30
- Completion
- 2012-09-30
Countries
- Canada
Study Locations
More Related Trials
-
Influenza Vaccine Dose-Response in Infants and Toddlers: Immunogenicity and Reactogenicity
NCT00710866 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity & Safety Study of Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years
NCT00929331 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route)
NCT01138397 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine
NCT01617239 ·Status: COMPLETED ·Phase: PHASE1
-
Influenza Burden Assessment in the United States, July1997 - up to April 2009
NCT01599390 ·Status: COMPLETED
-
Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?
NCT01001325 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Assess the Safety of a New Influenza Vaccine
NCT01104493 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults
NCT00989287 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects
NCT00630331 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults
NCT05827926 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older
NCT00329966 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Formulation
NCT00718146 ·Status: COMPLETED ·Phase: PHASE2
-
A Systematic Review of Studies of the Effect of Influenza Vaccine Against Mismatched Strains
NCT01416597 ·Status: COMPLETED
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to NON Elderly AND Elderly Subjects
NCT00518726 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults
NCT04956575 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pooled Analysis of Methodologically Harmonized Pragmatic Randomized Trials of High-Dose vs. Standard-Dose Influenza Vaccine Against Severe Clinical Outcomes
NCT06506812 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >= 18 and <= 64, Plus Revaccination
NCT00889889 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of the Cellular and the Humoral Immunogenicity, Safety of Different Trivalent Influenza Vaccines
NCT01119157 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults
NCT05868382 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.
NCT06178991 ·Status: COMPLETED ·Phase: PHASE3
-
Do Some Healthy Adults Consistently Have Systemic Reactions to Influenza Vaccines?
NCT02263027 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvanted Influenza Study Vaccine in Adults Aged 18 Years and Above
NCT01880697 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults
NCT05875961 ·Status: COMPLETED ·Phase: PHASE1
-
Tolerability and Immunogenicity of Fluval P Monovalent Influenza Vaccine
NCT01010893 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity Study of Split Influenza Virus Vaccine in Different Age Groups
NCT01654809 ·Status: COMPLETED ·Phase: PHASE4